|
Alitair is a specialty pharmaceutical company with a focus on the respiratory space. We have created a versatile patented drug delivery platform that allows us to create QD or BID respiratory therapies using trusted molecules in a convenient oral solid dosage form.
Our respiratory portfolio features out-licensed products that currently generate revenue for Alitair and internally-developed products, some of which are available for out-licensing.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
for more information about our technology and product candidates.
|
|
 |
|
|
